Product Comparison

Comparison Options

• Print
• Email

McKesson #	1199156	911398	330568	842097	795986
Description	PREVNAR 20™ Pneumonia Vaccine Indicated for People 6 Weeks of Age and Older Pneumococcal 20-valent Conjugate Vaccine [Diphtheria CRM197 Protein], Preservative Free 2.2 mcg - 4.4 mcg / 0.5 mL Injection Prefilled Syringe 0.5 mL	Pneumovax® 23 Pneumonia Vaccine Indicated for People 50 Years of Age and Older Pneumococcal 23 Vaccine Polyvalent 25 mcg / 0.5 mL Injection Prefilled Syringe 0.5 mL	Pneumovax® 23 Pneumonia Vaccine Indicated for People 50 Years of Age and Older Pneumococcal 23 Vaccine Polyvalent 25 mcg / 0.5 mL Injection Single-Dose Vial 0.5 mL	Prevnar 13® Pneumonia Vaccine Indicated for People 6 Weeks to 5 Years of Age and for People 50 Years of Age and Older Pneumococcal 13-valent Conjugate Vaccine [Diphtheria CRM197 Protein], Preservative Free 2.2 mcg - 4.4 mcg / 0.5 mL Injection Prefilled Syringe 0.5 mL	Prevnar 13® Pneumonia Vaccine Indicated for People 6 Weeks to 5 Years of Age and for People 50 Years of Age and Older Pneumococcal 13-valent Conjugate Vaccine [Diphtheria CRM197 Protein], Preservative Free 2.2 mcg - 4.4 mcg / 0.5 mL Injection Prefilled Syringe 0.5 mL
Manufacturer #	00005200002	00006483703	00006494300	00005197105	00005197102
Brand	PREVNAR 20™	Pneumovax® 23	Pneumovax® 23	Prevnar 13®	Prevnar 13®
Manufacturer	Pfizer (RSV Vaccines)	Merck	Merck	Pfizer (RSV Vaccines)	Pfizer (RSV Vaccines)
Invoice	PREVNAR 20, PFS 0.5ML UD	PNEUMOVAX, SYR 0.5ML (10/CT)	PNEUMOVAX, SDV 25MCG/0.5ML 0.5ML (10/PK)	PREVNAR 13, SYR 0.5ML 9PFIZ	PREVNAR 13, SYR 0.5ML (10/CT) 9WYETH
	Log In to Order	Log In to Order	Log In to Order	Log In to Order	Log In to Order
Comparison
Alternate Manufacturer Number	2348530			2021178	1614650
Container Type	Prefilled Syringe	Prefilled Syringe	Single-Dose Vial	Prefilled Syringe	Prefilled Syringe
Country of Origin	Unknown	United States	United States	Unknown	Unknown
Generic Drug Code	49791	43859	14287	28232	28232
Generic Drug Name	Pneumococcal 20-valent Conjugate Vaccine [Diphtheria CRM197 Protein], Preservative Free	Pneumococcal 23 Vaccine Polyvalent	Pneumococcal 23 Vaccine Polyvalent	Pneumococcal 13-valent Conjugate Vaccine [Diphtheria CRM197 Protein], Preservative Free	Pneumococcal 13-valent Conjugate Vaccine [Diphtheria CRM197 Protein], Preservative Free
NDC Number	00005200002	00006483703	00006494300	00005197105	00005197102
Product Dating	McKesson Acceptable Dating: we will ship >= 90 days	McKesson Acceptable Dating: we will ship >= 180 days	McKesson Acceptable Dating: we will ship >= 180 days	McKesson Acceptable Dating: we will ship >= 180 days	McKesson Acceptable Dating: we will ship >= 180 days
Strength	2.2 mcg - 4.4 mcg / 0.5 mL	25 mcg / 0.5 mL	25 mcg / 0.5 mL	2.2 mcg - 4.4 mcg / 0.5 mL	2.2 mcg - 4.4 mcg / 0.5 mL
Type	Intramuscular	Intramuscular or Subcutaneous	Intramuscular or Subcutaneous	Intramuscular	Intramuscular
User	Indicated for People 6 Weeks of Age and Older	Indicated for People 50 Years of Age and Older	Indicated for People 50 Years of Age and Older	Indicated for People 6 Weeks to 5 Years of Age and for People 50 Years of Age and Older	Indicated for People 6 Weeks to 5 Years of Age and for People 50 Years of Age and Older
Application	Pneumonia Vaccine	Pneumonia Vaccine	Pneumonia Vaccine	Pneumonia Vaccine	Pneumonia Vaccine
Dosage Form	Injection	Injection	Injection	Injection	Injection
Storage Requirements	Requires Refrigeration	Requires Refrigeration	Requires Refrigeration	Requires Refrigeration	Requires Refrigeration
UNSPSC Code	51201615	51201615	51201615	51201615	51201615
Volume	0.5 mL	0.5 mL	0.5 mL	0.5 mL	0.5 mL
Features and Benefits		PNEUMOVAX 23 is a vaccine indicated for active immunization for the prevention of pneumococcal disease caused by the 23 serotypes contained in the vaccine PNEUMOVAX 23 is approved for use in persons 50 years of age or older and persons aged >2 years who are at increased risk for pneumococcal disease Box of 10 single-dose, pre-filled Luer-Lok™ syringes with tip caps, color coded with a violet plunger rod and purple stripe on the syringe labels and cartons Store unopened and opened vials at 2° - 8°C (36° - 46°F)	PNEUMOVAX 23 is supplied as a single-dose vial of liquid vaccine, in a box of 10 single dose vials, color coded with a purple cap and stripe on the vial labels and cartons No dilution or reconstitution is necessary PNEUMOVAX 23 is approved for use in persons 50 years of age or older and persons aged ≥2 years who are at increased risk for pneumococcal disease	In children 6 weeks through 5 years of age, Prevnar 13 is indicated for active immunization for the prevention of invasive disease caused by Streptococcus pneumoniae serotypes 1, 3, 4, 5, 6A, 6B, 7F, 9V, 14, 18C, 19A, 19F and 23F In children Prevnar is also indicated for active immunization for the prevention of otitis media caused by Streptococcus pneumoniae serotypes 4, 6B, 9V, 14, 18C, 19F, and 23F No otitis media efficacy data are available for serotypes 1, 3, 5, 6A, 7F, and 19A In children 6 years through 17 years of age Prevnar 13 is indicated for active immunization for the prevention of invasive disease caused by S. pneumoniae serotypes 1, 3, 4, 5, 6A, 6B, 7F, 9V, 14, 18C, 19A, 19F and 23F In adults 50 and older, Prevnar 13 is indicated for the active immunization for the prevention of pneumonia and invasive disease caused by Streptococcus pneumoniae serotypes 1, 3, 4, 5, 6A, 6B, 7F, 9V, 14, 18C, 19A, 19F and 23F The tip cap and rubber plunger of the prefilled syringe do not contain latex Store Refrigerated at 2° to 8°C (36° to 46°F)	In children 6 weeks through 5 years of age, Prevnar 13 is indicated for active immunization for the prevention of invasive disease caused by Streptococcus pneumoniae serotypes 1, 3, 4, 5, 6A, 6B, 7F, 9V, 14, 18C, 19A, 19F and 23F In children Prevnar is also indicated for active immunization for the prevention of otitis media caused by Streptococcus pneumoniae serotypes 4, 6B, 9V, 14, 18C, 19F, and 23F No otitis media efficacy data are available for serotypes 1, 3, 5, 6A, 7F, and 19A In children 6 years through 17 years of age Prevnar 13 is indicated for active immunization for the prevention of invasive disease caused by S. pneumoniae serotypes 1, 3, 4, 5, 6A, 6B, 7F, 9V, 14, 18C, 19A, 19F and 23F In adults 50 and older, Prevnar 13 is indicated for the active immunization for the prevention of pneumonia and invasive disease caused by Streptococcus pneumoniae serotypes 1, 3, 4, 5, 6A, 6B, 7F, 9V, 14, 18C, 19A, 19F and 23F The tip cap and rubber plunger of the prefilled syringe do not contain latex Store Refrigerated at 2° to 8°C (36° to 46°F)